Dolutegravir dual therapy works well for both first line and maintenance treatment
Dapivirine vaginal ring effective and acceptable with longer use
Does Descovy have a role as PrEP in people who struggle with adherence?
Policing practices are consistently associated with HIV and risk behaviours among people who inject drugs
First trial results of new immune-modulating drugs presented in Mexico City
Could integrating HIV prevention into contraceptive services reduce infections among African women?
Starting PrEP does not lead to more STIs, youth survey in Chicago finds
Who stops taking PrEP, and why?
Islatravir plus doravirine may offer new dual therapy option
